Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B ROTHMAN

Showing results (1-10 of 606) with videos related to

Pageof 61
Sort By:
JAMA|January 7, 1998
Brain serotonin neurotoxicity and fenfluramine and dexfenfluramineR B Rothman
Synapse (New York, N.Y.)|May 7, 1999
Is phentermine an inhibitor of monoamine oxidase? A critical appraisalR B Rothman
NIDA Research Monograph|January 1, 1994
A review of the effects of dopaminergic agents in humans: implications for medication developmentR B Rothman
The Journal of Clinical Psychiatry|February 1, 1996
Smoking cessation in a patient being treated with fenfluramine plus phentermine for simple obesityR B Rothman
Annals of Internal Medicine|May 22, 2002
Anorexogen-related cardiac valvulopathyRichard B Rothman
The Journal of Clinical Investigation|December 2, 2016
Introduction of Peter AgrePaul B Rothman
Lancet (London, England)|April 28, 1999
Does phentermine inhibit monoamine oxidase?R B Rothman
Chest|November 18, 2000
The age-adjusted mortality rate from primary pulmonary hypertension, in age range 20 to 54 years, did not increase during the years of peak "phen/fen" useR B Rothman
Pediatrics|August 1, 1971
Improved method of lumbar puncture in the newborn and small infantF B Rothman
Synapse (New York, N.Y.)|October 1, 1992
A review of the role of anti-opioid peptides in morphine tolerance and dependenceR B Rothman
Pageof 61

Showing results (1-10 of 606) with videos related to

Sort By:
Pageof 61
JAMA|January 7, 1998
Brain serotonin neurotoxicity and fenfluramine and dexfenfluramineR B Rothman
Synapse (New York, N.Y.)|May 7, 1999
Is phentermine an inhibitor of monoamine oxidase? A critical appraisalR B Rothman
NIDA Research Monograph|January 1, 1994
A review of the effects of dopaminergic agents in humans: implications for medication developmentR B Rothman
The Journal of Clinical Psychiatry|February 1, 1996
Smoking cessation in a patient being treated with fenfluramine plus phentermine for simple obesityR B Rothman
Annals of Internal Medicine|May 22, 2002
Anorexogen-related cardiac valvulopathyRichard B Rothman
The Journal of Clinical Investigation|December 2, 2016
Introduction of Peter AgrePaul B Rothman
Lancet (London, England)|April 28, 1999
Does phentermine inhibit monoamine oxidase?R B Rothman
Chest|November 18, 2000
The age-adjusted mortality rate from primary pulmonary hypertension, in age range 20 to 54 years, did not increase during the years of peak "phen/fen" useR B Rothman
Pediatrics|August 1, 1971
Improved method of lumbar puncture in the newborn and small infantF B Rothman
Synapse (New York, N.Y.)|October 1, 1992
A review of the role of anti-opioid peptides in morphine tolerance and dependenceR B Rothman
Pageof 61